The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,318.00
Bid: 12,288.00
Ask: 12,292.00
Change: -52.00 (-0.42%)
Spread: 4.00 (0.033%)
Open: 12,326.00
High: 12,428.00
Low: 12,260.00
Prev. Close: 12,370.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 4-Oil drops as inventories and COVID vaccine halt threaten demand

Tue, 16th Mar 2021 05:48

* Germany, France, Italy suspend use of AstraZeneca shot

* Move threatens EU's already slow vaccination campaign

* U.S. inventories seen rising in data releases this week

* U.S. refineries take time to recover from 'big freeze'
(Updates prices)

By Shadia Nasralla

LONDON, March 16 (Reuters) - Oil prices fell for a third day
on Tuesday, as a recovery in demand was threatened by rising
U.S. inventories and moves by Germany, France and some other
European states to suspend the use of a major coronavirus
vaccine.

Brent was down $1.11 cents, or 1.6%, at $67.77 a
barrel by 1325 GMT. U.S. crude fell $1.17, or 1.7%, at
$64.22.

Germany, France and Italy said they would suspend the use of
the Oxford/AstraZeneca vaccine after reports about
possible serious side effects, although the World Health
Organization said there was no established link to the vaccine.

The moves deepen concerns about the slow pace of
vaccinations in the European Union, threatening an economic
recovery and fuel demand.

The pandemic eviscerated demand for oil. Prices have
recovered to levels seen before the global health crisis, but
gains have been capped as vaccine rollouts have proceeded slowly
in many countries.

In the United States, crude inventories are also rising as
refineries have taken time to recover fully from a "big freeze"
that halted their operations in Texas and elsewhere.

"Short-term direction will be set by the weekly U.S.
inventory reports," PVM analysts said in a note, adding that the
dollar's strength against other currencies also weighed on the
oil price.

Analysts expect another week of inventory gains when the
American Petroleum Institute, an industry group, reports on
crude stockpiles on Tuesday, followed by official numbers from
the Department of Energy on Wednesday.

Inventories rose by 12.8 million barrels in the week to
March 5, against forecasts for a rise of less than 1 million
barrels.

(Additional reporting by Aaron Sheldrick; Editing by Susan
Fenton and Edmund Blair)

More News
13 Feb 2024 09:32

LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 09:41

LONDON BROKER RATINGS: Deutsche Bank starts Deliveroo at 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
12 Feb 2024 09:12

Barclays sees "compelling" entry point at AstraZeneca after recent falls

(Sharecast News) - Barclays has kept an 'overweight' position on AstraZeneca despite the biopharma group's disappointing annual results last week, saying that the stock's recent underperformance provides an attractive entry point for investors.

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
9 Feb 2024 07:51

LONDON BRIEFING: Barclays buys Tesco's retail banking business

(Alliance News) - Stocks in London are called to open higher on Friday, closing off a busy corporate week.

Read more
8 Feb 2024 17:00

LONDON MARKET CLOSE: Softer earnings weigh on underperforming FTSE 100

(Alliance News) - London's FTSE 100 ended lower on Thursday, with mixed corporate updates keeping a lid on enthusiasm, while in New York the S&P 500 has the 5,000 point mark in touching distance.

Read more
8 Feb 2024 14:42

London close: Stocks slip as US jobless claims fall

(Sharecast News) - London markets experienced a downturn in trading on Thursday, with stocks relinquishing earlier gains as investors processed a decrease in jobless claims in the United States.

Read more
8 Feb 2024 12:08

LONDON MARKET MIDDAY: DS Smith surges on takeover approach from Mondi

(Alliance News) - Stock prices in London were mixed at midday Thursday, as markets struggled to find direction amid a mixed wave of corporate updates and earnings.

Read more
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.